An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic ...
Results from the largest-ever clinical trial of its kind found administering a synthetic protein can reduce bleeding and improve outcomes for certain patients at the highest risk of continued bleeding ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
DEAR DR. ROACH: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...
What Is Fesilty, and Why Does It Matter? Fesilty (fibrinogen, human-chmt) is a newly approved treatment for sudden bleeding episodes in both children and adults with a rare condition called congenital ...
SCHENECTADY — Continuing the hospital’s dedication and work in lung cancer and pulmonology, Ellis Medicine opened the Nan and Hugh Murphy Interventional Procedures Suite on Wednesday morning. The main ...
Sanofi SAN-0.16%decrease; red down pointing triangle said two bleeding disorder treatments for both chronic and acute conditions have been approved in China, expanding its hematology offerings in the ...
Sanofi said two bleeding disorder treatments for both chronic and acute conditions have been approved in China, expanding its hematology offerings in the country. The French pharmaceutical company ...
Two bleeding disorder treatments for both chronic and acute conditions, Qfitlia and Cablivi, have been approved in China. Broadcom Reports Earnings After the Close Today. Analysts Expect Strong ...
PHILADELPHIA – More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an ...
About The Study: Cryopreserved platelets did not meet the predefined threshold for noninferiority in hemostatic effectiveness at 24 hours after intensive care unit admission. Additional predefined end ...
Turkish giants Galatasaray said Super Eagles forward Victor Osimhen will undergo treatment for muscular ’strain and bleeding’ following a MRI examination at the club’s Acıbadem International Hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results